NSCLC STAGE II
Clinical trials for NSCLC STAGE II explained in plain language.
Never miss a new study
Get alerted when new NSCLC STAGE II trials appear
Sign up with your email to follow new studies for NSCLC STAGE II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a soy compound shield lungs from radiation damage?
Disease control Recruiting nowThis phase II trial tests whether a drug called BIO 300, made from a soy compound, can prevent severe lung inflammation (pneumonitis) in people with early-stage non-small cell lung cancer who also have interstitial lung disease. About 25 participants will receive BIO 300 along wi…
Matched conditions: NSCLC STAGE II
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New combo therapy aims to shrink lung tumors before surgery
Disease control Recruiting nowThis study tests whether giving a mix of two immunotherapy drugs (sintilimab and IBI310) plus chemotherapy before surgery can shrink tumors in people with stage II-III non-small cell lung cancer. About 54 participants will receive the treatment and then have surgery. The main goa…
Matched conditions: NSCLC STAGE II
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can a tailored home exercise program help lung cancer patients? new study aims to find out
Symptom relief Recruiting nowThis pilot study is testing whether a personalized exercise regimen, delivered via telehealth, is feasible and safe for people with stage II or III non-small cell lung cancer who are receiving chemotherapy or immunotherapy and surgery. Twenty participants will follow a home-based…
Matched conditions: NSCLC STAGE II
Phase: NA • Sponsor: University of Utah • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC